Nanotheranostic strategies for cancer immunotherapy
Despite advancements in cancer immunotherapy, heterogeneity in tumor response impose
barriers to successful treatments and accurate prognosis. Effective therapy and early …
barriers to successful treatments and accurate prognosis. Effective therapy and early …
Highly sensitive detection of the immune checkpoint PD-L1-positive circulating tumor cells based on steric hindrance
Y Gong, Y Yao, W Cheng, C Duan, D Li… - Analytical …, 2022 - ACS Publications
Programmed-death ligand 1 (PD-L1), as one of major immune checkpoints, is highly
expressed on cancer cells and participates in the immune escape process of tumor cells …
expressed on cancer cells and participates in the immune escape process of tumor cells …